XML 38 R11.htm IDEA: XBRL DOCUMENT
v3.25.0.1

Impairment and Other Charges (Notes) | 12 Months Ended
--- | ---
Dec. 31, 2024
Impairments and Other Charges [Abstract] |
Impairments and Other Charges | Impairments and Other Charges The following table presents various pre-tax charges we recorded during the years ended December 31, 2024 and 2022 which are reflected within “Impairments and other charges” on our consolidated statements of operations.
| Year Ended December 31,
Millions of dollars | 2024 | 2023 | 2022
Severance costs | $ | 63 |  | $ | — |  | $ | — |
Impairment of assets held for sale | 49 |  | — |  | — |
Cybersecurity | 35 |  | — |  | — |
Gain on investment | (43) |  | — |  | — |
Receivables | — |  | — |  | 202 |
Long-lived asset impairments | — |  | — |  | 100 |
Inventory costs and write-downs | — |  | — |  | 70 |
Other | 12 |  | — |  | (6) |
Total impairments and other charges | $ | 116 |  | $ | — |  | $ | 366 |
During the year ended December 31, 2024, we recorded $116 million net charges, of which $45 million was attributable to our Completion and Production segment, $34 million was attributable to our Drilling and Evaluation segment, and $37 million was attributable to Corporate and other. These charges included $63 million in severance expense as we rationalized global headcount to reflect growth expectations in addition to a $49 million impairment associated with a strategic decision to market for sale a portion of our chemical business. Also, a s disclosed within our Form 8-Ks filed with the SEC on August 23, 2024, and September 3, 2024, we became aware that an unauthorized third party gained access to certain of our systems. As a result, we incurred $35 million in expenses related to the engagement of external advisors to assess and remediate the effects of the activity, and restore our systems, as well as legal fees, payroll related costs, and other expenses. Additionally, we recognized a gain of $43 million related to a fair value adjustment on an equity investment during the year ended December 31, 2024. During the year ended December 31, 2023, there were no amounts recorded in impairment and other charges. During the year ended December 31, 2022, due to Russia’s invasion of Ukraine and resulting sanctions imposed on Russia, we made the decision to sell our Russian operations and completed the sale in the third quarter of 2022. We wrote down the disposal group to fair value less costs to sell, which resulted in a pre-tax charge of $344 million. Of this pre-tax charge, approximately $131 million was attributable to our Completion and Production segment, approximately $178 million was attributable to our Drilling and Evaluation segment, and $35 million was selling costs and was attributable to Corporate and other. We no longer conduct operations in Russia. Additionally, during the first quarter of 2022, we recorded a pre-tax charge of $22 million primarily related to the write down of all our assets in Ukraine. Included in this charge is a $16 million allowance for credit loss as we do not expect to collect our receivables in Ukraine. Long-lived asset impairments include impairments of property, plant, and equipment.

X
- Definition Impairments and Other Charges [Abstract] + References No definition available. + Details
Name: | hal_ImpairmentsandOtherChargesAbstract
Namespace Prefix: | hal_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure of costs incurred for restructuring including, but not limited to, exit and disposal activities, remediation, implementation, integration, asset impairment, and charges against earnings from the write-down of assets. + References No definition available. + Details
Name: | us-gaap_RestructuringImpairmentAndOtherActivitiesDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration